The Zhejiang University team developed a multi-material projection-based 3D bioprinting (PBBP) system employing a synergistic cleaning strategy called "fluid-controlled rinsing with negative ...

D Bioprinting Market The global 3D bioprinting market is set to grow from USD 2.78 Bn in 2025 to USD 7.39 Bn by 2032, registering a CAGR o ...

Food printing has been around for a while, but some experiments have taken it to strange new places. Scientists and chefs ...

Q4 2024 Management View CEO Jeffrey Graves emphasized the impact of a change in accounting estimate for the regenerative medicine program, which resulted in a $9 million reduction in Q4 revenue. He ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

D Systems Corporation’s DDD share price has dipped by 19.49%, which has investors questioning if this is right time to buy.

Advancements in AI, 3D printing, and Virtual Surgical Planning are revolutionizing healthcare by improving precision, ...

The Global 3D Cell Culture Market is expected to witness a double-digit growth rate by 2027. Some of the key factors driving ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

PhD Defense: From Organoids to Bioprinting; Advancing the Building Blocks of Breast Tissue Engineering ...

Schematic Overview of the Development of a Bespoke Islet-specific Microenvironment Using Bioprinting Technology to Enhance ...